Bacterial superantigens induce peripheral unresponsiveness in CD4+ T cell populations that express appropriate Vβ chains. We have used Vβ3/Vα11 T cell receptor transgenic (Tg) mice and the Vβ3-specific superantigen staphylococcal enterotoxin A (SEA) to further investigate the mechanisms that contribute to such unresponsiveness. As in other models, in vivo exposure to SEA rendered the Tg CD4+ cells unresponsive to subsequent restimulation in vitro with antigen or mitogens. However, when the SEA-treated CD4+ cells were completely purified away from all other contaminating cells, they regained the ability to proliferate and secrete cytokines. Moreover, enriched CD4−CD8− cells from the SEA-treated mice suppressed the responses of fresh control CD4+ cells in mixed cultures indicating that the apparent “anergy” was both transferable and reversible. Further analysis demonstrated that interferon γ, but not the Fas receptor, played a critical role in the suppression.
Transferable Anergy: Superantigen Treatment Induces CD4+ T Cell Tolerance That Is Reversible and Requires CD4−CD8− Cells and Interferon γ
Address correspondence to Dr. Susan L. Swain, Director, Trudeau Institute, P.O. Box 59, 100 Algonquin Ave., Saranac Lake, NY 12983. Phone: 518-891-3080; FAX: 518-891-5126; E-mail: [email protected]. The present address of K.A. Cauley is the Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405.
1Abbreviations used in this paper: AICD, activation-induced cell death; C′, complement; DN, CD4−CD8− double negative; F/S, forward and side light scatter; mRNA, messenger RNA; PCCF, peptide fragment of pigeon cytochrome; PI, propidium iodide; RT, reverse transcriptase; SAg, superantigen; SEA, staphylococcal enterotoxin A; TdR, [H3]thymidine; TdT, terminal deoxynucleotidyl transferase; Tg, transgenic.
Linda S. Cauley, Keith A. Cauley, Fillipa Shub, Gail Huston, Susan L. Swain; Transferable Anergy: Superantigen Treatment Induces CD4+ T Cell Tolerance That Is Reversible and Requires CD4−CD8− Cells and Interferon γ. J Exp Med 7 July 1997; 186 (1): 71–81. doi: https://doi.org/10.1084/jem.186.1.71
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement